Search Results - O. A. Rachinskaya

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Use of Cytogenetic Analysis Methods for Assessing the Quality of Cell Lines in Biomedical Cell Products

    Use of Cytogenetic Analysis Methods for Assessing the Quality of Cell Lines in Biomedical Cell Products by O. A. Rachinskaya, V. A. Merkulov

    Published 2018-03-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Advanced Therapy Medicines Based on Oncolytic Viruses (Part II: Development and Authorisation of IMLYGIC®)

    Advanced Therapy Medicines Based on Oncolytic Viruses (Part II: Development and Authorisation of IMLYGIC®) by E. V. Melnikova, O. A. Rachinskaya, V. A. Merkulov

    Published 2021-12-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Advanced Therapy Medicines Based on Oncolytic Viruses (Part I: Development and Authorisation of Products in China)

    Advanced Therapy Medicines Based on Oncolytic Viruses (Part I: Development and Authorisation of Products in China) by E. V. Melnikova, O. A. Rachinskaya, V. A. Merkulov

    Published 2021-10-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    The Aspects of Manufacturing and Quality Control of Somatic Medications Based on Mesenchymal Stem Cells

    The Aspects of Manufacturing and Quality Control of Somatic Medications Based on Mesenchymal Stem Cells by O. A. Rachinskaya, E. V. Melnikova, V. A. Merkulov

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    FEATURES OF QUALITY CONTROL STRATEGY FOR DRUGS BASED ON VIABLE SKIN CELLS

    FEATURES OF QUALITY CONTROL STRATEGY FOR DRUGS BASED ON VIABLE SKIN CELLS by O. A. Rachinskaya, E. V. Melnikova, V. A. Merkulov

    Published 2023-02-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Current trends and risks associated with the use of therapies based on genome editing

    Current trends and risks associated with the use of therapies based on genome editing by O. A. Rachinskaya, E. V. Melnikova, V. A. Merkulov

    Published 2023-10-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Quality control programmes for induced pluripotent stem cell-derived medicinal products

    Quality control programmes for induced pluripotent stem cell-derived medicinal products by E. V. Melnikova, O. A. Rachinskaya, I. S. Semenova, V. A. Merkulov

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Evaluation of the Activity of Drugs Containing Human Cell Lines: Promising Approaches and Requirements of Regulatory Bodies

    Evaluation of the Activity of Drugs Containing Human Cell Lines: Promising Approaches and Requirements of Regulatory Bodies by A. A. Chaplenko, E. V. Melnikova, O. A. Rachinskaya, Yu. V. Olefir

    Published 2020-05-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Features of Preclinical Studies of Cell Therapy Products

    Features of Preclinical Studies of Cell Therapy Products by E. V. Melnikova, M. D. Khorolsky, O. A. Rachinskaya, V. A. Merkulov

    Published 2020-12-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Treatment of Genetic Diseases: Current Trends in the Development of Biomedical Cell Products

    Treatment of Genetic Diseases: Current Trends in the Development of Biomedical Cell Products by O. A. Rachinskaya, M. A. Vodyakova, E. V. Melnikova, V. A. Merkulov

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    International Practice of Storing Human Cell Lines Intended for Clinical Use

    International Practice of Storing Human Cell Lines Intended for Clinical Use by O. A. Rachinskaya, A. A. Chaplenko, E. V. Melnikova, I. S. Semenova, Yu. V. Olefir

    Published 2018-12-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    International Practices of Registration and Use of Drugs for Gene Therapy in Clinical Practice

    International Practices of Registration and Use of Drugs for Gene Therapy in Clinical Practice by E. V. Melnikova, O. V. Merkulova, A. A. Chaplenko, O. A. Rachinskaya, V. A. Merkulov

    Published 2020-05-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Evaluation of Cell Line Identity Using RTCA Profiling for Quality Control of Products Containing Viable Human Cells

    Evaluation of Cell Line Identity Using RTCA Profiling for Quality Control of Products Containing Viable Human Cells by M. A. Vodyakova, O. A. Rachinskaya, N. S. Pokrovsky, I. S. Semenova, E. V. Melnikova, V. A. Merkulov

    Published 2023-09-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Methodological aspects of the development of product files for biomedical cell products

    Methodological aspects of the development of product files for biomedical cell products by E. V. Melnikova, O. A. Rachinskaya, O. V. Merkulova, I. S. Semenova, E. O. Kozhevnikova, V. A. Merkulov

    Published 2021-07-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Justification of Methodological Approaches to Identification Testing of Biomedical Cell Products

    Justification of Methodological Approaches to Identification Testing of Biomedical Cell Products by E. V. Melnikova, O. A. Rachinskaya, G. A. Trusov, M. D. Khorolsky, I. S. Semenova, N. V. Tereshkina, V. A. Merkulov

    Published 2019-03-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    International Approaches to Regulation of Medicinal Products Containing Viable Human Cells

    International Approaches to Regulation of Medicinal Products Containing Viable Human Cells by E. V. Melnikova, A. A. Goryaev, M. V. Savkina, O. V. Merkulova, A. A. Chaplenko, O. A. Rachinskaya, I. S. Semenova, G. A. Trusov, V. A. Merkulov

    Published 2018-09-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: